Reiter Yoram

Medicine & Life Sciences

1. Antibodies 100%
2. Peptides 97%
3. Immunotoxins 80%
4. Immunoglobulin Variable Region 58%
5. HLA-A2 Antigen 56%
6. Neoplasms 54%
7. T-Cell Antigen Receptor Specificity 50%
8. T-Lymphocytes 49%
9. T-Cell Antigen Receptor 46%
10. Disulfides 43%
11. Major Histocompatibility Complex 41%
12. Antigens 39%
13. Single-Chain Antibodies 34%
14. Histocompatibility Antigens Class I 28%
15. Exotoxins 28%
16. T-Lymphocyte Epitopes 27%
17. Neoplasm Antigens 24%
18. Antigen-Presenting Cells 23%
19. Immunoglobulin Fragments 21%
20. Immunotherapy 21%
21. Bacteriophages 20%
22. Chimeric Antigen Receptors 19%
23. Heterografts 18%
24. Epitopes 17%
25. ATP Binding Cassette Transporter, Subfamily B, Member 1 17%
26. Melanoma-Specific Antigens 17%
27. Antigen Presentation 17%
28. Melanoma 16%
29. Complement Membrane Attack Complex 16%
30. Proteins 15%
31. Dendritic Cells 15%
32. Pseudomonas 14%
33. K562 Cells 13%
34. MHC binding peptide 12%
35. CD1d Antigen 11%
36. Ligands 11%
37. Cross-Priming 11%
38. Monophenol Monooxygenase 11%
39. Therapeutics 10%
40. Langerhans Cells 10%
41. SARS Virus 10%
42. CTLA-4 Antigen 10%
43. Clone Cells 9%
44. Cytotoxic T-Lymphocytes 9%
45. Autoimmune Diseases 9%
46. Differentiation Antigens 8%
47. Nude Mice 8%
48. Telomerase 8%
49. Polynucleotides 7%
50. Libraries 7%